Barry J. Simon - 25 Aug 2023 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role
Director
Signature
/s/ Jason Liljestrom, as Attorney-in-Fact
Issuer symbol
IBRX
Transactions as of
25 Aug 2023
Net transactions value
$0
Form type
4
Filing time
28 Aug 2023, 21:01:14 UTC
Previous filing
09 Jun 2023
Next filing
06 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBRX Restricted Stock Units Award $0 +114,399 $0.000000 114,399 25 Aug 2023 Common Stock 114,399 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
F2 Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award shall vest on September 1, 2023 and 57,200 of the RSUs subject to the award shall vest on January 31, 2024.